Pharmaceutical - Xofigo, North America


Current filters:

XofigoNorth America

Popular Filters

First sales of Xofigo triggers 50 million-euro milestone payment to Algeta from Bayer


Norway's Algeta (OSE: ALGETA) announced today (May 30) that Xofigo (radium Ra 223 dichloride) injection…

AlgetaBayerFinancialMarkets & MarketingNorth AmericaPharmaceuticalXofigo

Fast FDA approval for Bayer's new drug for advanced prostate cancer, Xofigo


The US Food and Drug Administration yesterday (May 15) approved Xofigo (radium Ra 223 dichloride, initially…

AlgetaAstellas PharmaBayerNorth AmericaOncologyPharmaceuticalRegulationXofigo

Back to top